ending 30 June 2017 1 Revenue from sales Total revenue from sales amounted to THB 3,628 million, up by THB 127 million or 3.6%, divided into the proportion of domestic and overseas sales at the ratio of 55
last year ending 30 June 2017 1 Revenue from sales Total revenue from sales amounted to THB 3,628 million, up by THB 127 million or 3.6%, divided into the proportion of domestic and overseas sales at the
Administrative expenses 345.64 125.89 Cost of amortization 2.58 2.41 Finance costs 45.86 6.53 Finance costs (net) 37.80 3.10 Proportion of cost of medical treatment / revenue of medical treatment 73.97 67.76
Administrative expenses 311.52 148.24 Cost of amortization 4.15 3.02 Finance costs 53.71 9.04 Finance costs (net) 49.56 6.02 Proportion of cost of medical treatment / revenue of medical treatment 89.78 71.00
Pursuant to the SEC’s rules, all Thailand ESG Funds are required to invest in companies operating sustainably and receiving SET ESG Ratings as eligible assets* at an average proportion of at least 80
the changes in the holding of individuals, thegroup percentage of acquisition/disposition, the group percentage after theacquisition/disposition and the person(s) under Section 258 of the Securities and
: warrant or convertible debenture or other securitiesconvertible to stock. In case of group report, disclose the changes in the holding of individuals, thegroup percentage of acquisition/disposition, the
, thegroup percentage of acquisition/disposition, the group percentage after theacquisition/disposition and the person(s) under Section 258 of the Securities and Exchange Act B.E.2535 . Preliminary version